OMOP Concept 37559503
Ibrutinib and Rituximab-rite
StandardRegimenHemOnc128367Regimen
Maps from
0
Descendants
0
Valid from
17 Nov 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(24)Roll up to these when you need a wider cohort.
- 1Anti-CD20 antibody-containing regimen
- 1BTK inhibitor-containing regimen
- 1ibrutinib
- 1Ibrutinib-containing regimen
- 1Multiagent regimen
- 1Rituximab-rite-containing regimen
- 1Synthetic regimen
- 1Targeted therapy
- 1Targeted therapy-containing regimen
- 1TKI-containing regimen
- 2BTK inhibitor
- 2EGFR inhibitor
- 2Generic class-based regimen
- 2ITK inhibitor
- 2Named class-based regimen
- 2TEC inhibitor
- 2TXK inhibitor
- 2WHO Essential Cancer Medicine
- 3Growth factor inhibitor
- 3Tyrosine kinase inhibitor
- 3WHO Essential Medicine
- 4Kinase inhibitor
- 4Targeted therapeutic
- 5Antineoplastics by class effect
Get this concept via the API
Resolve Ibrutinib and Rituximab-rite - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/37559503?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card